Episode 39: Abbott FreeStyle Libre - Accuracy, Simplicity and What's Next

Suggest guests or get in contactMichael Skarlatos from Abbott UK Medical Affairs joins John Pemberton for the second manufacturer episode of the CGM Series. A former diabetes specialist dietitian at University Hospitals of Leicester, Michael brings real clinical experience to an honest breakdown of the FreeStyle Libre 2 Plus and 3 Plus.This episode covers:- Why Abbott accuracy data qualifies these sensors for insulin dosing: ICGM approved, 20/20 performance ~95-96%, outside-40/40 error rate 0.2%- What 70% smaller means in practice: form factor, stigma, and the all-in-one applicator on Libre 3 Plus- Pump integrations now and the roadmap: CamAPS FX, Omnipod 5, and what is coming- Libreview: why Abbott moved off Glooko and what population health management enables- Libreview Pro in SystmOne and EMIS with SNOMED-coded CGM metrics- A critical data nuance: glucose measured every minute on the patient app but recorded every 5 minutes in clinical downloads- Continuous ketone monitoring: what Abbott has in development and who benefits mostCHAPTERS00:00 Introduction and CGM Series overview00:57 Michaels background and Leicester NHS Trust02:25 Moving from NHS to Abbott Medical Affairs03:27 Accuracy credentials: ICGM approval and 20/20 performance05:44 FreeStyle Libre 3 Plus: size and form factor09:25 Pump integrations: CamAPS FX, Omnipod 5, and the roadmap10:19 ICGM interoperability: US vs CE marking in Europe12:05 Fifteen-day wear period12:28 Abbott market history: free samples and patient-led adoption14:04 Simplicity of onboarding and multi-language support16:58 Starter clinics: taking onboarding off the HCP19:33 Libreview and population health management23:21 EHR integration, SNOMED codes, and QOF implications25:46 Practical tips: Bluetooth connectivity and the app cache29:23 Minute-by-minute data vs five-minute trend recording30:58 Low glucose event thresholds and hypo underreporting31:42 Continuous ketone monitoring: what is coming from Abbott37:52 CGM beyond type 1 and patient advocacy40:17 Closing thoughtsLINKSShow notes: https://theglucoseneverlies.com/episode-38-freestyle-libre-abbott/YouTube: https://youtu.be/IW1sa5APHU8CGM Series: https://theglucoseneverlies.com/10-13-cgm-series/GNL Explorers: https://theglucoseneverlies.com/gnl-grace/Buzzsprout: https://www.buzzsprout.com/2451357/18982022Apple Podcasts: https://podcasts.apple.com/gb/podcast/the-glucose-never-lies/id1795741144Spotify: https://open.spotify.com/show/2MlGlz2G8LsbDnuGtAh77WThis content is for educational exploration only. Not medical advice.Support GNL: https://buy.stripe.com/9B63cx4UO3KEdKC0Sp7Re00The Glucose Never Lies® is a registered trademark of The GNL Ltd. Company No. 16733595. UK VAT No. GB 516 3272 08.DisclaimerThis podcast is for education and informational purposes only. It does not constitute medical advice and is not a substitute for individualised care.The Glucose Never Lies® is independent by designWe do not accept sponsorships and advertising. We operate via education grants and donations from listeners who value independence. So, consider:Buying the GNL a Coffee:https://www.buymeacoffee.com/jspfree2EnquiriesCollaboration: John Pemberton — [email protected]: Anjanee Kohli — [email protected] The Glucose Never Lies®Website: https://theglucoseneverlies.com/Instagram: https://www.instagram.com/theglucoseneverliesLinkedIn: https://www.linkedin.com/company/theglucoseneverliesLinkedIn: John Pemberton: https://www.linkedin.com/in/john-pemberton-587104361/X: https://twitter.com/GlucoseNLiesDisclaimer This content is for informational purposes only and does not constitute medical advice.© The Glucose Never Lies Ltd. All rights reserved.